Turning cancer cells back to normal
Scientists have discovered that inhibiting a protein found in stem cells causes cancer tumour cells to revert back to normal cells.
Archives for April 29, 2007
Resisting the call for new antibacterials?
While the media calls out for new antibacterials, the majority of large pharmaceutical companies seem disinterested in investing in new treatments, leaving smaller biotechs to pick up the gauntlet.
Clinical outsourcing more common in early stages
Clinical trial sponsors are outsourcing the majority of clinical work in Phase I and gradually bringing functions back in-house as compounds move through the development stages.
PharmaFab agrees to stop unapproved drugs production
US contract manufacturer PharmaFab has agreed to stop the manufacturing and distribution of some of its drugs after regulators found they were produced illegally.
Boehringer steps up contract manufacturing in Mexico
Boehringer Ingelheim is stepping up its commercial contract manufacturing operation in Mexico to feed the ravenous North American market.
Pfizer's turn to collaborate with BMS
Bristol-Myers Squibb (BMS) has announced its second collaboration this year with a fellow big pharma firm, aimed once again at reducing the inherent risk of drug development.